These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 32515873)

  • 21. Progression of Clinical and Eye Movement Markers in Preataxic Carriers of Machado-Joseph Disease.
    de Oliveira CM; Leotti VB; Cappelli AH; Rocha AG; Ecco G; Bolzan G; Kersting N; Saraiva-Pereira ML; Jardim LB
    Mov Disord; 2023 Jan; 38(1):26-34. PubMed ID: 36129443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive-affective manifestations since premanifest phases of Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.
    Bolzan G; Müller Eyng ME; Leotti VB; Saraiva-Pereira ML; Jardim LB
    Cortex; 2024 Feb; 171():370-382. PubMed ID: 38091940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ADC mapping of neurodegeneration in the brainstem and cerebellum of patients with progressive ataxias.
    Della Nave R; Foresti S; Tessa C; Moretti M; Ginestroni A; Gavazzi C; Guerrini L; Salvi F; Piacentini S; Mascalchi M
    Neuroimage; 2004 Jun; 22(2):698-705. PubMed ID: 15193598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cervical Spinal Cord Degeneration in Spinocerebellar Ataxia Type 7.
    Hernandez-Castillo CR; Diaz R; Rezende TJR; Adanyeguh I; Harding IH; Mochel F; Fernandez-Ruiz J
    AJNR Am J Neuroradiol; 2021 Sep; 42(9):1735-1739. PubMed ID: 34210665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retinopathy associated with Machado--Joseph disease (spinocerebellar ataxia 3) with CAG trinucleotide repeat expansion.
    Isashiki Y; Kii Y; Ohba N; Nakagawa M
    Am J Ophthalmol; 2001 Jun; 131(6):808-10. PubMed ID: 11384587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dystonia in Machado-Joseph disease: Clinical profile, therapy and anatomical basis.
    Nunes MB; Martinez AR; Rezende TJ; Friedman JH; Lopes-Cendes I; D'Abreu A; França MC
    Parkinsonism Relat Disord; 2015 Dec; 21(12):1441-7. PubMed ID: 26552869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. White matter damage is related to ataxia severity in SCA3.
    Kang JS; Klein JC; Baudrexel S; Deichmann R; Nolte D; Hilker R
    J Neurol; 2014 Feb; 261(2):291-9. PubMed ID: 24272589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cerebral metabolic topography of spinocerebellar ataxia type 3.
    Meles SK; Kok JG; De Jong BM; Renken RJ; de Vries JJ; Spikman JM; Ziengs AL; Willemsen ATM; van der Horn HJ; Leenders KL; Kremer HPH
    Neuroimage Clin; 2018; 19():90-97. PubMed ID: 30035006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longitudinal Analysis of the Relation Between Clinical Impairment and Gray Matter Degeneration in Spinocerebellar Ataxia Type 7 Patients.
    Contreras A; Ramirez-Garcia G; Chirino A; Morgado-Valle C; Pasaye EH; Hernandez-Castillo C; Díaz R; Fernandez-Ruiz J; Beltran-Parrazal L
    Cerebellum; 2021 Jun; 20(3):346-360. PubMed ID: 33184781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progression of microstructural damage in spinocerebellar ataxia type 2: a longitudinal DTI study.
    Mascalchi M; Toschi N; Giannelli M; Ginestroni A; Della Nave R; Nicolai E; Bianchi A; Tessa C; Salvatore E; Aiello M; Soricelli A; Diciotti S
    AJNR Am J Neuroradiol; 2015 Jun; 36(6):1096-101. PubMed ID: 25882284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spinocerebellar ataxias: genotype-phenotype correlations in 104 Brazilian families.
    Teive HA; Munhoz RP; Arruda WO; Lopes-Cendes I; Raskin S; Werneck LC; Ashizawa T
    Clinics (Sao Paulo); 2012; 67(5):443-9. PubMed ID: 22666787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developmental and neurodegenerative damage in Friedreich's ataxia.
    Rezende TJR; Martinez ARM; Faber I; Girotto Takazaki KA; Martins MP; de Lima FD; Lopes-Cendes I; Cendes F; França MC
    Eur J Neurol; 2019 Mar; 26(3):483-489. PubMed ID: 30326180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6.
    Reetz K; Costa AS; Mirzazade S; Lehmann A; Juzek A; Rakowicz M; Boguslawska R; Schöls L; Linnemann C; Mariotti C; Grisoli M; Dürr A; van de Warrenburg BP; Timmann D; Pandolfo M; Bauer P; Jacobi H; Hauser TK; Klockgether T; Schulz JB;
    Brain; 2013 Mar; 136(Pt 3):905-17. PubMed ID: 23423669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive Impairments in Spinocerebellar Ataxia Type 10 and Their Relation to Cortical Thickness.
    Chirino-Pérez A; Vaca-Palomares I; Torres DL; Hernandez-Castillo CR; Diaz R; Ramirez-Garcia G; Fernandez-Ruiz J
    Mov Disord; 2021 Dec; 36(12):2910-2921. PubMed ID: 34327752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spinal cord damage in Machado-Joseph disease.
    Fahl CN; Branco LM; Bergo FP; D'Abreu A; Lopes-Cendes I; França MC
    Cerebellum; 2015 Apr; 14(2):128-32. PubMed ID: 25370748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dominantly inherited ataxias: lessons learned from Machado-Joseph disease/spinocerebellar ataxia type 3.
    Paulson HL
    Semin Neurol; 2007 Apr; 27(2):133-42. PubMed ID: 17390258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Corticospinal tract involvement in spinocerebellar ataxia type 3: a diffusion tensor imaging study.
    Inada BSY; Rezende TJR; Pereira FV; Garcia LÁL; da Rocha AJ; Neto PB; Barsottini OGP; França MC; Pedroso JL
    Neuroradiology; 2021 Feb; 63(2):217-224. PubMed ID: 32876704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imbalanced optimal feedback motor control system in spinocerebellar ataxia type 3.
    Li L; Chen H; Deng L; Huang Y; Zhang Y; Luo Y; Ou P; Shi L; Dai L; Chen W; Chen H; Wang J; Liu C
    Eur J Neurol; 2024 Sep; 31(9):e16368. PubMed ID: 38923784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural signature in SCA1: clinical correlates, determinants and natural history.
    Martins Junior CR; Martinez ARM; Vasconcelos IF; de Rezende TJR; Casseb RF; Pedroso JL; Barsottini OGP; Lopes-Cendes Í; França MC
    J Neurol; 2018 Dec; 265(12):2949-2959. PubMed ID: 30324307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stage-Dependent Biomarker Changes in Spinocerebellar Ataxia Type 3.
    Faber J; Berger M; Wilke C; Hubener-Schmid J; Schaprian T; Santana MM; Grobe-Einsler M; Onder D; Koyak B; Giunti P; Garcia-Moreno H; Gonzalez-Robles C; Lima M; Raposo M; Melo ARV; de Almeida LP; Silva P; Pinto MM; van de Warrenburg BP; van Gaalen J; de Vries J; Oz G; Joers JM; Synofzik M; Schols L; Riess O; Infante J; Manrique L; Timmann D; Thieme A; Jacobi H; Reetz K; Dogan I; Onyike C; Povazan M; Schmahmann J; Ratai EM; Schmid M; Klockgether T
    Ann Neurol; 2024 Feb; 95(2):400-406. PubMed ID: 37962377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.